With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also hoping to win over national coverage from CMS.
Mobile and digital health technologies have become so popular that they are almost ubiquitous, but it is easy to forget that these are still relatively new fields in terms of clinical effectiveness, a new literature review shows.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.